Citation Impact
Citing Papers
Catalytic Functionalization of C(sp2)H and C(sp3)H Bonds by Using Bidentate Directing Groups
2013 Standout
Functionality map analysis of the active site cleft of human thrombin
1996 StandoutNobel
Allosteric Inhibitor Development Targeting HIV‐1 Integrase
2011
Catalytic Three‐Component Ugi Reaction
2008 StandoutNobel
Recent advances in organocatalytic methods for the synthesis of disubstituted 2- and 3-indolinones
2012 Standout
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
2002
Selection of boron reagents for Suzuki–Miyaura coupling
2013 Standout
Specific Interaction of the Recombinant Disintegrin-like Domain of MDC-15 (Metargidin, ADAM-15) with Integrin αvβ3
1998
Thrombin signalling and protease-activated receptors
2000 StandoutNature
On the antitumor properties of novel cyclometalated benzimidazole Ru(ii), Ir(iii) and Rh(iii) complexes
2013
Constitutive Protease-activated Receptor-2-mediated Migration of MDA MB-231 Breast Cancer Cells Requires Both β-Arrestin-1 and -2
2004 StandoutNobel
Protease-activated receptor 3 is a second thrombin receptor in humans
1997 Nature
The ATP-gated P2X1 Receptor Plays a Pivotal Role in Activation of Aspirin-treated Platelets by Thrombin and Epinephrine
2008 StandoutNobel
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
A dual thrombin receptor system for platelet activation
1998 Nature
New first and second generation inhibitors of human immunodeficiency virus-1 integrase
2011
Fibulin-5/DANCE is essential for elastogenesis in vivo
2002 StandoutNatureNobel
The creation of an antithrombotic surface by apyrase immobilization
2010 StandoutNobel
Supported gold nanoparticles as catalysts for organic reactions
2008 Standout
Biaryl Phosphane Ligands in Palladium‐Catalyzed Amination
2008 Standout
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
1997 StandoutNature
Metargidin, a Membrane-anchored Metalloprotease-Disintegrin Protein with an RGD Integrin Binding Sequence
1996
Recent advances in Sonogashira reactions
2011 Standout
Solid-Phase Synthesis of Biologically Active Benzoannelated Nitrogen Heterocycles: An Update
2008
Proteinase-activated receptors: novel mechanisms of signaling by serine proteases
1998 Standout
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Remarkable Potential of the α-Aminophosphonate/Phosphinate Structural Motif in Medicinal Chemistry
2011
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
The Golden Age of Transfer Hydrogenation
2015 Standout
Differential regulation of human keratinocyte growth and differentiation by a novel family of protease-activated receptors.
1997
Design and Synthesis of Thrombin Inhibitors: Analogues of MD-805 with Reduced Stereogenicity and Improved Potency
1999
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Crystal Structures of Protein-Bound Cyclic Peptides
2019
Analyzing Reaction Rates with the Distortion/Interaction‐Activation Strain Model
2017 Standout
Oxidative Coupling between Two Hydrocarbons: An Update of Recent C–H Functionalizations
2015 Standout
Hydroamination: Direct Addition of Amines to Alkenes and Alkynes
2008 Standout
The Potential of Palladacycles: More Than Just Precatalysts
2005
Engineered Biosynthesis of β‐Alkyl Tryptophan Analogues
2018 StandoutNobel
Solid-Phase Synthesis of N-Substituted Glycine Oligomers (α‑Peptoids) and Derivatives
2010
The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity
2000
Mild metal-catalyzed C–H activation: examples and concepts
2016 Standout
Heterocycles in drugs and drug discovery
2012
Palladium-Catalyzed Meta-Selective C–H Bond Activation with a Nitrile-Containing Template: Computational Study on Mechanism and Origins of Selectivity
2013
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Palladium-Catalyzed Transformations of Alkyl C–H Bonds
2016 Standout
Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein–Protein Interfaces
2020
Use of Lawesson's Reagent in Organic Syntheses
2007 Standout
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Copper-Catalyzed Synthesis of Mixed Alkyl Aryl Phosphonates
2014 StandoutNobel
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
A facile and efficient synthesis of diethyl α,α‐chlorofluoroalkanephosphonates
2010
Catalytic Hydrogenation of α‐Iminophosphonates as a Method for the Synthesis of Racemic and Optically Active α‐Aminophosphonates
2008
Selected Patented Cross-Coupling Reaction Technologies
2006 Standout
Catalytic Dehydrogenative Cross-Coupling: Forming Carbon−Carbon Bonds by Oxidizing Two Carbon−Hydrogen Bonds
2011 Standout
Nucleophilic Substitution at Phosphorus (SN2@P): Disappearance and Reappearance of Reaction Barriers
2006
The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin
1996
PubChem 2023 update
2022 Standout
Engineering Biomolecular Self‐Assembly at Solid–Liquid Interfaces
2020 StandoutNobel
Vesicles and Liposomes: A Self‐Assembly Principle Beyond Lipids
2003 Standout
Rational Tuning of Fluorobenzene Probes for Cysteine‐Selective Protein Modification
2018 StandoutNobel
Structural and Pharmacological Effects of Ring-Closing Metathesis in Peptides
2010
Alkenylpyridine and alkenylamine complexes of palladium
2001
Supramolecular Helical Systems: Helical Assemblies of Small Molecules, Foldamers, and Polymers with Chiral Amplification and Their Functions
2016 Standout
Ruthenium(II)-Catalyzed C–H Bond Activation and Functionalization
2012 Standout
Matrix Proteases in Health and Disease
2012
Hydroborations catalysed by transition metal complexes
1997
Putting polyphosphates to the test: evidence against platelet-induced activation of factor XII
2013 StandoutNobel
The Chemistry of Neutron Capture Therapy
1998 Standout
o-Fluoroazobenzenes as Readily Synthesized Photoswitches Offering Nearly Quantitative Two-Way Isomerization with Visible Light
2012 Standout
Diversity Oriented Clicking (DOC): Divergent Synthesis of SuFExable Pharmacophores from 2‐Substituted‐Alkynyl‐1‐Sulfonyl Fluoride (SASF) Hubs
2020 StandoutNobel
PubChem in 2021: new data content and improved web interfaces
2020 Standout
The chemistry of boron analogues of biomolecules
1994
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Engineering Metal Organic Frameworks for Heterogeneous Catalysis
2010 Standout
Palladium-Catalyzed Ligand-Directed C−H Functionalization Reactions
2010 Standout
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Stereoselective Addition of Dimethyl Thiophosphite to Imines
2004
Towards control of χ-space: Conformationally constrained analogues of Phe, Tyr, Trp and His
1999
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Preparation of a photoresponsive molecularly imprinted polymer containing fluorine-substituted azobenzene chromophores
2011
Works of John Deadman being referenced
Inhibition of human α-thrombin by a phosphonate tripeptide proceeds via a metastable pentacoordinated phosphorus intermediate 1 1Edited by R. Huber
2001
Thrombin Receptor-Activating Peptide Does Not Stimulate Platelet Procoagulant Activity
1994
Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: Selection of the scaffold
2010
Characterization of a Class of Peptide Boronates with Neutral P1 Side Chains as Highly Selective Inhibitors of Thrombin
1995
Hydroxyperfluoroazobenzenes: novel inhibitors of enzymes of androgen biosynthesis
1990
Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site
2011
Interrogating HIV integrase for compounds that bind- a SAMPL challenge
2014
Crystal structure of the HIV‐1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site
2010
Design of a series of bicyclic HIV-1 integrase inhibitors. Part 2: Azoles: Effective metal chelators
2010
Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses
2010
Binaphthyl scaffolded peptoids via ring-closing metathesis reactions and their anti-bacterial activities
2009
New peptide boronic acid inhibitors of thrombin
1992
The synthesis of 1-aminobenzylphosphonic acids from benzylidenediphenylmethylamines, for use as structural units in antithrombotic tripeptides
1994
Design of a novel class of bifunctional thrombin inhibitors, synthesised by the first application of peptide boronates in solid phase chemistry
1997
New cyclic peptides via ring-closing metathesis reactions and their anti-bacterial activities
2008
Facile routes to 1-halo-1-alkyl boronic esters as precursors for novel thrombin inhibitors
1994
Synthesis ofpara-Substituted 3-Formyl Arylboronic Esters
2002
Thrombin Receptor Activating Peptide (TRAP) Stimulates Mitogenesis, c-fos and PDGF-A Gene Expression in Human Vascular Smooth Muscle Cells
1995
The facile synthesis of O,O-dialkyl 1-aminoalkanephosphonates
1993
Rhodium(I)-catalysed hydroboration of 1-halo-1-alkenes
1994
Assembly of Urokinase Receptor-Mediated Plasminogen Activation Complexes Involves Direct, Non-Active-Site Interactions between Urokinase and Plasminogen
1998
The facile synthesis of O,O-Dialkyl α-halobenzylphosphonates from O,O-Dialkyl α-hydroxybenzylphosphonates
1996
Crystal Structures of Two Palladacycles from the C–H Activation of 2-(Thiophen-2-yl)pyridine
2010
Synthetic RGD peptides derived from the adhesive domains of snake-venom proteins: evaluation as inhibitors of platelet aggregation
1993
Crystallographic Structures of Human α-Thrombin Complexed to Peptide Boronic Acids Lacking a Positive Charge at P1. Evidence of Novel Interactions
1997
Preferential antagonism of the interactions of the integrin αIIbβ3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins
1994